Senior Research Assistant / Research Assistant I

Applications are invited for appointment as

(Ref.: 537641), to commence as soon as possible for one year, with the possibility of renewal subject to satisfactory performance and funding availability. Applicants should possess a Master's degree in Cancer Biology, Cancer Immunology, Biomedical Sciences or a related field, and demonstrate exceptional experimental, writing, and communication abilities. Preference will be given to candidates with translational research experience in cancer immunology, antibody-based therapeutics, and/or antibody/protein engineering; as well as cell/organoid culture, cellular/molecular biology, antibody/protein characterization, flow cytometry, animal studies, and cancer-related research work. Applicants should have good communication skills, be self-motivated, have the ability to multi-task with attention to detail, be organized and be able to work independently as well as in a multidisciplinary team. The appointee will work under the supervision of Professor Stephanie Ma on translational research projects relating to novel cancer therapeutics development with a focus on targeting cancer stemness using hepatocellular carcinoma as a model system, that is part of a collaborative project. For further information, please contact Professor Stephanie Ma at stefma@hku.hk . Details of Professor Ma's research can also be found at http://thesmalab.com/. Information about the School of Biomedical Sciences can be obtained at http://www.sbms.hku.hk/ . A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits. The University only accepts online application for the above post at the University's Careers site ( https://jobs.hku.hk ). Applicants should apply online and upload an up-to-date C.V. Review of applications will start

and continue until January 13, 2027, or until the post is filled, whichever is earlier. The University is an equal opportunities employer and is committed to equality, ethics, inclusivity, diversity and transparency